MedPath

Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

Phase 4
Recruiting
Conditions
Laparoscopic Hysterectomy
Registration Number
NCT06690307
Lead Sponsor
Affiliated Hospital of Nantong University
Brief Summary

This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.

Detailed Description

The controlled group will receive sulfentanil for PCIA, and the test group will receive hydrocodone for PCIA. NRS scores at 1, 6, 24 and 48 hours post-surgery will be recorded. The usage of rescue analgesics and adverse events will also be recorded.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
64
Inclusion Criteria
  • selective laparoscopic hysterectomy
  • general anesthesia
  • ASA classification I - III
  • aged 18 - 65 years
Exclusion Criteria
  • allergy to oxycodone or any other drugs will be used in the study
  • preoperative opioids medication
  • opioids abuse
  • hepatic or renal dysfunction
  • cardiovascular or pulmonary dysfunction
  • lack of full civil capacity or refuse to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
NRS scores6 hours after surgery

Postoperative pain will be evaluated on a 11point number rating scale (NRS): 0 means no pain; and 10 means worst pain imaginable.

Secondary Outcome Measures
NameTimeMethod
NRS scores30 days after surgery

Postoperative pain will be evaluated on a 11point number rating scale (NRS): 0 means no pain; and 10 means worst pain imaginable.

rescue analgesics usagefrom the end of surgery to the first usage (up to 48 hours post-surgery)

time to the first use of rescue analgesics

PCIA pressing times48 hours after surgery

total pressing times and effective pressing times

anal exhaust timefrom the end of surgery to the first anal exhaust (up to 48 hours post-surgery)
adverse eventswithin 48 hours after surgery

dizziness, drowsiness, nausea and vomiting, intestinal paralysis, skin itching, respiratory depression, intestinal obstruction, severe allergic reactions, and serious cardiovascular adverse events

Trial Locations

Locations (1)

Affiliated hospital of Nantong University

🇨🇳

Nantong, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath